News in brief: PoC testing for HbA1c funded by Medicare; Romosozumab on PBS for osteoporosis; Adrenal insufficiency medical alert jewellery unworn;

Point-of-care HbA1c testing available on Medicare From November 1, point-of-care HbA1c tests will be listed on Medicare for the management and monitoring of established diabetes, the government has announced. The listing will fund approximately 190,000 tests in a move intended to reduce turnaround times, increase patient convenience and improve access particularly for patients based in regional, rural ...

Already a member?

Login to keep reading.

© 2021 the limbic